Hidradenitis Suppurativa Written Action Plan

University of Arizona8 enrolled

Overview

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Hidradenitis Suppurativa

Interventions

Verbal consultationBEHAVIORAL

Verbal consultation only without written information before receiving written action plan

Written Action PlanBEHAVIORAL

Written handout of treatment plan and disease management strategies

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Has a diagnosis of HS Exclusion Criteria: * Has been exposed to a written action plan for HS before

Locations (1)

University of Arizona

Tucson, Arizona, United States

Outcomes

Primary Outcomes

Visits to high-cost care settings

Number of visits to ER, urgent care, or hospitalizations because of HS

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.